Related Experiment Video
Updated: Nov 20, 2025
04:34
Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
1.4K
Adherence to Cognitive Behavior Therapy for Insomnia: An Updated Systematic Review
Sommer Agnew1, Annie Vallières2, Ailie Hamilton1
1School of Psychological Sciences and Health, Graham Hills Building, 40 George Street, Glasgow, G1 1QE, UK.
Sleep Medicine Clinics
|January 24, 2021
Summary
Measuring adherence to cognitive behavior therapy for insomnia is complex. Current methods vary, hindering consensus on optimal adherence and its impact on treatment outcomes.
Area of Science:
- Behavioral Science
- Sleep Medicine
- Clinical Psychology
Background:
- Adherence to cognitive behavior therapy for insomnia (CBT-I) is crucial for treatment efficacy.
- Previous adherence measurement methods were often subjective and prone to bias.
Purpose of the Study:
- To review and synthesize findings from studies measuring adherence to CBT-I.
- To highlight the evolution of adherence assessment methods in CBT-I research.
- To identify challenges and needs in establishing a consensus for adherence measurement.
Main Methods:
- Systematic review of 53 studies measuring adherence to CBT-I.
- Analysis of methodological advancements in adherence assessment.
- Examination of heterogeneity in adherence operationalization across studies.
Main Results:
- An increasing trend towards more complex and less biased adherence assessment methods.
- Significant heterogeneity in how adherence is defined and measured across studies.
- Inability to draw firm conclusions on adherence-outcome relationships or predictors due to methodological variations.
Conclusions:
- A need exists for a standardized approach to measuring adherence in CBT-I.
- Methodological heterogeneity currently prevents a clear understanding of optimal adherence levels and influencing factors.
- Further research with consistent adherence measurement is required to establish its relationship with insomnia treatment outcomes.
More Related Videos
Related Concept Videos
01:19Management of Insomnia
390
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
390
01:27Insomnia
253
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
253
01:24Substance Use Disorders Affecting Sleep
277
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
277
01:14CNS Depressants: Barbiturates and Benzodiazepines
860
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
860
02:07Blind Procedures
12.5K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.5K
01:15REM Sleep Behavior Disorder
900
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
900